The estimated Net Worth of Carsten Thiel is at least $3.73 Milhão dollars as of 28 February 2017. Carsten Thiel owns over 3,783 units of Karyopharm Therapeutics Inc stock worth over $25,056 and over the last 10 years Carsten sold KPTI stock worth over $3,709,061.
Carsten has made over 16 trades of the Karyopharm Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Carsten sold 3,783 units of KPTI stock worth $495,611 on 28 February 2017.
The largest trade Carsten's ever made was selling 4,584 units of Karyopharm Therapeutics Inc stock on 14 October 2016 worth over $551,364. On average, Carsten trades about 1,339 units every 26 days since 2015. As of 28 February 2017 Carsten still owns at least 33,860 units of Karyopharm Therapeutics Inc stock.
You can see the complete history of Carsten Thiel stock trades at the bottom of the page.
Carsten's mailing address filed with the SEC is C/O ALEXION PHARMACEUTICALS, INC., 352 KNOTTER DRIVE, CHESHIRE, CT, 06410.
Over the last 11 years, insiders at Karyopharm Therapeutics Inc have traded over $149,223,596 worth of Karyopharm Therapeutics Inc stock and bought 562,763 units worth $10,312,371 . The most active insiders traders include Deepika Pakianathan, Ltd Czernik Marcin Hadjimic..., eMikael Dolsten. On average, Karyopharm Therapeutics Inc executives and independent directors trade stock every 12 days with the average trade being worth of $26,350. The most recent stock trade was executed by Michael Mano on 4 September 2024, trading 3,971 units of KPTI stock currently worth $2,859.
karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com
Karyopharm Therapeutics Inc executives and other stock owners filed with the SEC include: